U.S. patent application number 13/447356 was filed with the patent office on 2012-10-18 for preparation for repairing cartilage tissue, especially articular cartilage defects.
This patent application is currently assigned to Zimmer Orthobiologics, Inc.. Invention is credited to Peter Bittmann, Martin Frenz, Simona Berardi Vilei, Philipp Wagner.
Application Number | 20120263683 13/447356 |
Document ID | / |
Family ID | 32913654 |
Filed Date | 2012-10-18 |
United States Patent
Application |
20120263683 |
Kind Code |
A1 |
Vilei; Simona Berardi ; et
al. |
October 18, 2012 |
PREPARATION FOR REPAIRING CARTILAGE TISSUE, ESPECIALLY ARTICULAR
CARTILAGE DEFECTS
Abstract
Provided herein are preparations for repairing enchondral or
osteochondral defects (4) by implantation, said preparations
comprising a cartilage element (A) and optionally a bone element
(B) which is connected to the cartilage element (A). The cartilage
element (A) can contain cells during the implantation or is
populated after the implantation with cells migrating from
surrounding tissue. The aim is to better equip the cartilage
element (A) of one such preparation for integration into the
surrounding tissue and/or for an easy-to-achieve, primary
stability. To this end, said cartilage element is not homogeneously
embodied but has different characteristics in a peripheral and/or
basal region (2, 3) to those in a central region (3). Said
differing characteristics (A) relate to the structure and/or
composition of the matrix used and/or to the cells established in
the matrix, and are not used to prevent the migration of cells into
the preparation from the surrounding tissue.
Inventors: |
Vilei; Simona Berardi;
(Lodrino, CH) ; Bittmann; Peter; (Zurich, CH)
; Wagner; Philipp; (Gland, CH) ; Frenz;
Martin; (Muensingen, CH) |
Assignee: |
Zimmer Orthobiologics, Inc.
Austin
TX
|
Family ID: |
32913654 |
Appl. No.: |
13/447356 |
Filed: |
April 16, 2012 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10547437 |
Jun 16, 2006 |
8173162 |
|
|
PCT/CH2004/000093 |
Feb 23, 2004 |
|
|
|
13447356 |
|
|
|
|
Current U.S.
Class: |
424/93.7 |
Current CPC
Class: |
A61F 2250/0014 20130101;
A61F 2/30767 20130101; A61F 2002/30062 20130101; A61F 2002/30235
20130101; A61F 2/30965 20130101; A61F 2002/30004 20130101; A61F
2230/0013 20130101; A61L 27/56 20130101; A61F 2210/0004 20130101;
A61F 2002/30224 20130101; A61F 2250/0015 20130101; A61P 19/00
20180101; A61F 2002/30225 20130101; A61F 2/28 20130101; A61L
27/3612 20130101; A61L 27/3654 20130101; A61F 2/3872 20130101; A61L
27/3608 20130101; A61F 2002/3092 20130101; A61L 27/3817 20130101;
A61L 2430/06 20130101; A61F 2310/00293 20130101; A61F 2230/0069
20130101; A61F 2002/30131 20130101; A61F 2/30756 20130101; A61L
27/3852 20130101; A61F 2310/00365 20130101; A61F 2002/30006
20130101 |
Class at
Publication: |
424/93.7 |
International
Class: |
A61K 35/32 20060101
A61K035/32; A61P 19/00 20060101 A61P019/00 |
Foreign Application Data
Date |
Code |
Application Number |
Feb 26, 2003 |
CH |
20030296/03 |
Claims
1-18. (canceled)
19. An implant for a cartilage defect, comprising: an ex vivo
prepared porous matrix populated with cells having chondrogenic
potential; a peripheral region of the matrix having an outer
surface for positioning adjacent native cartilage tissue
surrounding the defect; a central region of the matrix having an
outer surface adjacent an inner surface of the peripheral region; a
basal region having an upper surface adjacent a lower surface of
the peripheral region and a lower surface of the central region,
the basal region having a lower surface for disposal adjacent bone
and between the lower surfaces of the peripheral and central
regions and the bone; and wherein the basal region includes cells
of a different phenotypic potential than the cells in the central
and/or peripheral region.
20. The implant of claim 19, wherein the cells in the basal region
have an osteogenic potential and the cells in the central and/or
peripheral region have a chondrogenic potential.
21. The implant of claim 19, wherein the matrix is populated with
cells before implantation.
22. The implant of claim 21, wherein the matrix is populated by
applying a cell suspension.
23. The implant of claim 22, wherein the cell suspension is applied
via aspiration.
24. The implant of claim 19, wherein the matrix is populated with
cells in vitro.
25. The implant of claim 24, wherein the cells have chondrogenic
potential.
26. The implant of claim 24, wherein the matrix is cultured in
vitro prior to implantation.
27. The implant of claim 26, wherein the matrix is cultured for a
time period of two days to six weeks.
28. The implant of claim 27, wherein the matrix is cultured for a
time period of two weeks to six weeks.
29. The implant of claim 19, wherein the matrix further comprises a
bone part.
30. The implant of claim 29, wherein the bone part includes calcium
phosphate.
31. The implant of claim 30, wherein the calcium phosphate is
porous.
32. The implant of claim 29, wherein the matrix comprises calcium
phosphate.
33. The implant of claim 29, wherein the matrix is suitable for
repairing an osteochondral defect.
34. The implant of claim 19, wherein the matrix is at least
partially biodegradable.
35. The implant of claim 34, wherein the matrix comprises a
resorbable polymer.
36. The implant of claim 19, wherein the matrix comprises
collagen.
37. The implant of claim 19, wherein the matrix is
cross-linked.
38. The implant of claim 19, wherein the matrix is lyophilized.
Description
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation of and claims the benefit
of priority under 35 U.S.C. .sctn.120 to U.S. patent application
Ser. No. 10/547,437, entitled "PREPARATION FOR REPAIRING CARTILAGE
TISSUE, ESPECIALLY ARTICULAR CARTILAGE DEFECTS," filed on Jun. 16,
2006, which application is a nationalization under 35 U.S.C. 371 of
PCT/CH2004/000093, filed on Feb. 23, 2004, and published as WO
2004/075940 on Sep. 10, 2004, which claimed priority to Switzerland
Patent Application Serial No. 20030296/03, filed on Feb. 26, 2003,
which applications and publications are incorporated herein by
reference in their entirety.
[0002] The invention is in the field of medical technology and
concerns a preparation according to the preamble of the first
independent claim. The preparation is used for repairing cartilage
tissue, in particular, for repairing defects in articular
cartilage.
[0003] A known method for repairing enchondral articular cartilage
defects, i.e. articular cartilage defects which affect only the
cartilage layer, but not the bone tissue beneath the cartilage
layer, comprises introduction of cells having a chondrogenic
potential (chondrocytes, stem cells, etc.) in suspension, in a gel,
or in an advantageously resorbable matrix into the defect site. In
order to reliably hold the introduced materials in the defect site
immediately after the operation and during the healing phase, for
example, a piece of periosteum is sutured over the defect site.
Suitable matrix materials for the repairing enchondral defects are,
for example, described in the publications U.S. Pat. No. 6,352,558
and WO-99/19005 (Geistlich). These matrix materials are multilayer
membranes based on collagen and, before being introduced into the
defect site, they are cut to the size of the defect site. These
membranes comprise a matrix layer that consists, in particular, of
collagen H and has a sponge-like structure suitable for being
seeded with chondrocytes or other cells having chondrogenic
potential.
[0004] Furthermore, the membranes comprise a barrier layer which,
on implantation, is facing towards the subchondral bone plate. This
barrier layer consists, in particular, of collagen I and III, and
its structure, which is significantly denser than the structure of
the matrix layer, is suitable for preventing migration of cells
from the bone tissue into the repair site and also for preventing
vascularization of the repair site. In order to retain the
aforementioned membrane in the defect site, a piece of periosteum
is sutured over it, in the way as mentioned above. It is also
proposed to provide the membrane with a barrier layer on both
sides, thus giving mechanical characteristics to the outer membrane
side which permit the membrane to be sutured to the surrounding
cartilage tissue.
[0005] Furthermore, it is known to repair osteochondral articular
cartilage defects, i.e. defects which not only concern the
articular cartilage tissue but also the bone tissue lying beneath
the cartilage tissue, by implantation of advantageously resorbable
preparations as, for example, described in publications WO 93/15694
and U.S. Pat. No. 5,152,791. These preparation comprise a cartilage
part and a bone part, wherein the two parts differ from one another
with regard to porosity and/or with regard to the material. The
preparations are usually implanted in appropriately prepared
openings (boreholes), wherein the opening has a somewhat smaller
cross section than the preparation. The thus formed, so-called
press-fit in the mechanically firmer bone tissue and the greater
depth of the anchorage, in comparison to preparations positioned in
enchondral defects, are usually sufficient to retain the implant in
the defect site in such away that it is able to remain in place
even if the repaired joint is allowed to be loaded.
[0006] From the description above, it is clear that in accordance
with the state of the art, it is necessary to either harvest
periosteum or to use a correspondingly equipped matrix (e.g. with
an outer barrier layer) in order to attain a sufficient, primary
stability, which guarantees that the implant will remain in the
defect site after implantation and during the healing phase.
Therein the harvesting of periosteum is a relatively complicated
operation and the corresponding equipment of the matrix may have a
negative effect on other matrix functions.
[0007] Furthermore, it is evident that in addition to the problem
of the primary stability of the implants, the problem regarding
integration or in-growth of the implant, or of the repair tissue
formed in its place during the healing phase, in the surrounding
tissue needs to be solved also. It is found that implant
integration in the cartilage tissue and in the subchondral bone
plate (or in corresponding repair tissue) is not satisfactory in
many cases.
[0008] The problem of the integration of an artificial cartilage
replacement part in viable cartilage tissue is the same for an
implant designed for repairing a meniscus, for example, for
replacing a part of the inner edge region of the meniscus, wherein
the implant is supposed to grow together with the cartilage tissue
of the rest of the meniscus.
[0009] The object of the invention is to create a preparation for
repairing defect sites in cartilage tissue, in particular for
repairing articular cartilage, wherein the preparation according to
the invention, in comparison to known preparations of the same
purpose, is to be improved with regard to integration and/or
primary stability and wherein the improvement is not to render the
implantation operation more demanding. The invention refers to the
repair of cartilage tissue, wherein the preparation in accordance
with the invention is used to repair, for example, enchondral
defects in joints or menisci and comprises only one part (cartilage
part) which is to replace cartilage tissue, or wherein the
preparation is used to repair osteochondral defects in joints and
comprises in addition to the cartilage part a bone part for
replacing bone tissue, which bone part is arranged adjacent to the
cartilage part.
[0010] The objet is achieved by the preparation, as it is defined
in the claims.
[0011] In contrast to corresponding preparations according to the
state of the art, the cartilage part of the preparation in
accordance with the invention is not homogeneous, but comprises a
peripheral region (region adjacent to surrounding cartilage tissue
after implantation) and/or a basal region (region adjacent to the
subchondral bone plate after implantation or bordering the bone
part of an implant), which peripheral and/or basal regions have
characteristics which are suitable for enhancing integration and/or
primary stability of the preparation and do not prevent cell
migration, whereas the rest of the cartialge part, i.e. a central
region does not have such characteristics, but is equipped for an
optimal regeneration of cartilage tissue. It is found that using a
cartilage part being best suited in different regions for different
repair functions, it becomes possible to get improvements regarding
integration and/or primary stability without impairment of the
formation of functional repair tissue in the central region.
[0012] A matrix of the cartilage part of the preparation in
accordance with the invention is at least partially resorbable and
is based, for example, on collagen. The matrix may be seeded with
cells having a chondrogenic potential and may possibly be cultured
in vitro before implantation. The preparation may also be implanted
without cells to be later populated by repair cells migrating into
the matrix from the surrounding tissue. The above named
characteristics of the peripheral and/or basal region of the
cartilage part, which characteristics are different from the
characteristics of the central region, belong to at least one of
the following groups: characteristics of the matrix structure,
characteristics of the matrix composition, and characteristics of
the cells populating the matrix.
[0013] The invention is based, in particular, on the finding that
for good integration of the repair tissue in surrounding tissue
(cartilage and/or bone), it is advantageous, like in a healing
wound, if little differentiated cells (for example, stem cells) are
available in the integration region, in particular cells which are
not highly differentiated but are rather more mobile and better
capable of proliferation. On the other hand, for quick and
successful regeneration of cartilage tissue in the central region,
it is advantageous if highly differentiated cells are available,
i.e. chondrocytes or cells which are, regarding there degree of
differentiation, not greatly different from chondrocytes. Such
cells are known not to be very mobile and not to be capable of much
proliferation.
[0014] For attaining at the same time formation of good cartilage
repair tissue and good integration of this cartilage repair tissue
in the surrounding tissue, it is possible to use, instead of an
appropriate selection of cells differing in regard to their degree
of differentiation, or in addition to the latter, for example, the
following measures: [0015] for facilitating cell mobility and cell
proliferation, the porosity of the matrix is selected to be greater
in the peripheral and/or basal region than in the central region,
wherein possibly additional measures regarding primary stability
are needed. [0016] for differentiating cells populating the matrix
before implantation or cells which migrate into the matrix after
implantation in a desired manner, the basal and/or peripheral
region are equipped with factors in a way different from the
central part.
[0017] The following detailed description of the invention refers
to the following Figs., wherein:
[0018] FIG. 1 shows an exemplary embodiment of the preparation in
accordance with the invention, which embodiment is suitable for
implantation in an enchondral defect site in articular cartilage,
and the correspondingly prepared defect site;
[0019] FIG. 2 shows a meniscus repaired with a preparation in
accordance with the invention;
[0020] FIGS. 3 to 5 show sections through further exemplary
embodiments of the preparation in accordance with the
invention.
[0021] FIG. 1 shows an exemplary embodiment of the preparation in
accordance with the invention. The embodiment is suitable for
repairing an enchondral defect in articular cartilage and
comprises, for this reason, a cartilage part A only. The
preparation, or the cartilage part respectively, has a central
region 1, a peripheral region 2, and a basal region 3. The
preparation is implanted with the basal region 3 facing towards the
defect site 4, wherein the defect site may be suitably prepared
before implantation. The defect site extends, through the cartilage
layer 5, to the subchondral bone plate 6. In the implanted state,
the basal region 3 of the preparation lies on the native
subchondral bone plate 6.
[0022] The preparation has a thickness adapted to the thickness of
the cartilage layer 5 to be repaired, i.e. a thickness of
approximately 1-3 mm if used for repairing human articular
cartilage. The flat expansion of the preparation is to be adapted
to the defect site; the preparation has, for example, the form of a
circular disk with a diameter of 3-10 mm. The peripheral region 2
and the basal region 3 of the preparation comprise, depending on
the embodiment, a larger or a smaller part of the total volume of
the preparation, but in most cases, the central region 1 assumes
the largest part of the volume.
[0023] Especially in the case of preparations for the repair of
enchondral defect sites in articulate cartilage, it is advantageous
to design and/or to equip both the peripheral region 2 and the
basal region 3 differently from the central region 1. However, it
is also possible to do this for the peripheral region 2 only, so
that the central region 1 extends over the entire thickness of the
preparation, or for the basal region 3 only, so that the central
region 1 extends over the entire flat expansion of the
preparation.
[0024] FIG. 2 shows a further exemplary embodiment of the
preparation in accordance with the invention. This embodiment is
suitable for replacing an inner edge region of a meniscus 7. The
preparation, which comprises again a cartilage part A only is shown
in the implanted position. Since the cartilage tissue of the
meniscus 7 is not grown together with bone tissue, as is the case
for articular cartilage, the preparation needs to be integrated
only laterally in cartilage tissue of the meniscus, and for this
reason, comprises only a central region 1 and a peripheral region
2, but no basal region.
[0025] FIGS. 3 and 4 show in section two further exemplary
embodiments of the preparation in accordance with the invention.
The preparations according to FIGS. 2 and 3 essentially correspond
to the preparation shown in FIG. 1, which is suitable for repairing
an enchondral defect and comprises a cartilage part A only, but the
peripheral region 2 and the basal region 3 (FIG. 3) or only the
peripheral region 2 (FIG. 4) comprise additional subregions 2', 3',
2'', which, in turn, have different characteristics in comparison
to the rest of the peripheral or basal region. Advantageous such
characteristics are described further below.
[0026] FIG. 5 shows a preparation suitable for repairing an
osteochondral defect in a joint. For this reason, the preparation
comprises not only a cartilage part A, but also a bone part B,
attached to the cartilage part A. The cartilage part A is shaped,
for example, as shown in FIG. 1, 3, or 4, or it has only a
peripheral region 2 (possibly with a subregion 2') having
characteristics different from the characteristics of the central
region 1, which extends over the entire thickness of the cartilage
element A.
[0027] The matrix of the preparation in accordance with the
invention or of the cartilage part A of such a preparation
respectively is suitable for being populated with cells, i.e. the
matrix has an open porosity and consists of a correspondingly
selected and/or correspondingly coated material. The matrix is at
least partially biodegradable (resorbable). It consists in a per se
known manner, for example, predominantly of collagen, collagen and
calcium phosphate, or a resorbable polymer, for example, based on
lactic acid and/or glycolic acid. The matrix may also be a natural
product, i.e. it is, for example, produced from denatured cartilage
tissue.
[0028] A matrix based on collagen is, for example, produced in a
per se known manner, by cross-linking collagen fibers according to
the DHT method (dehydrothermal cross-linking). A desired porosity
is attained by a corresponding selection of method parameters. In
particular, a higher porosity is produced if the collagen
concentration is lower in the collagen base solution.
[0029] If the preparation in accordance with the invention
comprises a bone part B in addition to the cartilage part A, the
bone part is made in a per se known manner, for example, from a
porous calcium phosphate, which enhances bone regeneration and is
resorbed during the healing phase. The bone part may also consist
of a resorbable plastic based on lactic acid and/or glycolic
acid.
[0030] To produce a preparation in accordance with the invention,
the preparation comprising a cartilage part with a matrix of
collagen and a bone part with a matrix of porous calcium phosphate,
the collagen is, for example, placed on the calcium phosphate
substrate and is partially aspirated into it. Then, the collagen is
cross-linked according to the DHT method.
[0031] Cells which are seeded in the central region 1, or which are
to migrate into the central region, have the task, primarily, of
replacing the implanted matrix with an intercellular matrix which
is as cartilage-like as possible or to add such intercellular
matrix to the implanted matrix. Chondrocytes, or cells with
chondrogenic potential and in a stage of differentiation not far
from that of chondrocytes, are particularly suitable for this task.
It is found that in the peripheral and basal regions 2 and 3, where
newly formed tissue is to be bonded to the existing tissue, the
results are better when using, instead of chondrocytes, cells which
have chondrogenic potential but which are in a less differentiated
state than the cells of the central region. i.e., for example,
pluripotent stem cells or mesenchymal stem cells. These less
differentiated cells are also more mobile and better capable of
proliferation than the aforementioned chondrocytes or
chondrocyte-like cells. For a successful attachment of the repair
tissue on the subchondral bone plate, cells which have osteogenic
potential in addition to chondrogenic potential are likewise
suitable.
[0032] Populating the various regions of the cartilage part A of
the preparation in accordance with the invention with cells in
various states of differentiation can, for example, be attained by
using the same cells, for example, pluripotent or mesenchymal stem
cells. Initially only the central region is seeded and the cells
are then differentiated in vitro in the desired direction, by
making corresponding factors promoting such differentiation
available to the cells in the culture medium and/or in the matrix.
Such a preliminary culturing normally requires a time period of 2-6
weeks. When the cells populating the central region have attained
the desired degree of differentiation, the same cells as used for
the initial seeding of the central region are then seeded in the
peripheral and/or basal regions wherein it is advantageous to
provide in these regions factors that promote cell proliferation,
and possibly actors which promote cell differentiation to
chondrocytes and which are made to be available in a delayed manner
by e.g. being encapsulated.
[0033] A similar effect as achieved by preliminary culturing of the
cells seeded in the central region as described above is attained
by equipping the various regions of the matrix with various factors
and by seeding all regions with the same cells (for example, stem
cells) either immediately before implantation or with a short in
vitro culture (for example, two-day) before implantation.
Furthermore, the matrix may be implanted without cells, and the
repair tissue is formed by cells which migrate into the matrix from
surrounding tissue. In such a case, the central region is equipped
with factors suitable for promoting the desired differentiation,
wherein the factors are present in an immediately active form, and
the peripheral and/or basal regions are equipped with factors
suitable for promoting cell proliferation and present in an
immediately active form. It is possible also to provide the
peripheral and/or basal regions with factors promoting a desired
differentiation and being equipped for delayed release.
[0034] Natural articular cartilage has more cells in outer layers
than in inner layers bordering the subchondral bone plate.
According to this model, it is advantageous to populate the basal
region of the preparation in accordance with the invention with a
smaller cell density than the central region, or possibly not to
seed any cells therein. Cells migrating from the outermost region
of the subchondral bone plate or from a boundary area between the
cartilage tissue and the subchondral bone plate bordering the
defect site will then migrate into the basal region, the cells
having a state of differentiation suitable for this boundary area.
In order to promote the cell migration into the basal region, the
latter may be equipped with appropriate factors.
[0035] For only partial seeding the porous matrix with cells, for
example, a suitable cell suspension is placed on the matrix surface
and is aspirated into the matrix to the desired depth by applying a
suction force from the opposite side of the matrix. For seeding a
surface region with a small depth, it is possibly sufficient to
apply the cell suspension on the corresponding matrix surface.
[0036] To equipping a matrix with factors, the factors are, for
example, mixed with the matrix material and the mixture is then
lyophilized. It is also possible to bind the factors with suitable
linkers to the matrix or to add them, in dissolved or suspended
form, to the finished matrix.
[0037] In order to not limit the capability of the cells regarding
mobility and proliferation in the peripheral and/or basal regions
by the matrix, it is advantageous to equip the matrix with a higher
fraction of pores and/or with larger pores in the aforementioned
regions than in the central region.
[0038] However, a highly porous matrix, especially a highly porous
matrix in the peripheral region, is not suitable for suturing the
matrix directly to the surrounding native cartilage tissue, because
such a matrix has no sufficient tear resistance. For this reason
other means for a good primary stability are advantageously
provided. For example, a peripheral region or an outer subregion
(FIGS. 3 and 5: 2') of the matrix is reinforced with fibers (for
example, fibers of collagen II) or comprises a higher fraction of
proteoglycans. Both these measures impart sufficient mechanical
stability to the matrix regions for them to be able to be sutured
without having to dispense with the high porosity, which according
to the findings presented above is important, especially in this
region.
[0039] It is also possible to attain suturing capability by
reduction of the porosity, if this is done in an extremely small
subregion, as is shown in the preparation in accordance with FIG. 4
(subregion 2''). In a matrix produced by lyophilization and
consisting e.g. of collagen, a denser matrix structure in the
peripheral region can be produced by pouring the collagen mass onto
a cooling surface, wherein a very rapidly freezing and thus very
finely structured and dense layer is formed directly on the cooling
surface; this dense layer is then not completely removed as in
accordance with the state of the art, but it is only removed where
it would form the outer surface of the central preparation region.
The denser layer is left in the peripheral region of this outer
surface and forms a ring of a denser matrix material, which has a
tear resistance sufficient for being capable to be reliable sutured
to the surrounding cartilage material, even if the rest of the
peripheral region does not have this tear resistance.
[0040] If the peripheral region of a preparation according to the
invention has a mechanical stability which is not sufficient for
suturing, it is also possible to integrate a bonding agent in the
matrix in the peripheral and/or basal regions or in outer
subregions thereof. Such bonding agent is activated in situ, for
example, by means of lasers. A suitable such agent is, for example,
an albumin adhesive, to which indocyanine green (for example,
0.1%), is admixed, and which is activated with a laser of a
wavelength of 808 nm. A solution of the adhesive may be placed on
peripheral and/or basal surfaces of the preparation, to then be
fixed by lyophilization and to be activated by the laser after
implantation. The preparation layer equipped with the adhesive
advantageously has a thickness of no more than approx. 50
.mu.m.
[0041] To promote integration of the preparation in the tissue
surrounding the defect site, following the implantation, it is
further advantageous to add to the peripheral and/or basal
preparation regions inhibitors and/or antisense, which prevent or
reduce degradation of the formed repair tissue and of the original
tissue which directly borders thereon. Such advantageous additives
are, for example, inflammation inhibitors, protease inhibitors,
and/or apoptosis inhibitors.
[0042] The preparation in accordance with the invention is, for
example, a preparation in accordance with FIG. 3, comprising a
cartilage part of a matrix which has less porosity in the central
region than in the peripheral and basal regions, whose central
region is populated with cells which are in a state of higher
differentiation (achieved by appropriate preliminary culturing)
than cells in the peripheral and basal regions, and whose
peripheral and basal surfaces (subregions 2' and 3') comprise an
adhesive which can be activated with a laser. A similarly equipped
preparation in accordance with FIG. 2, comprises in an analogous
manner a central region of a smaller porosity than the peripheral
region and being populated with further differentiated cells.
Furthermore, an outer subregion of the peripheral region 2 is
equipped with an adhesive.
[0043] A similar preparation which is to be populated only
immediately before implantation with, for example, stem cells, or
only after implantation with cells that migrate from the
surroundings, has the same matrix, wherein the central region
contains immediately acting factors suitable for promoting cell
differentiation, and the peripheral and basal regions contain
immediately acting factors promoting cell proliferation and delayed
acting factors promoting cell differentiation.
[0044] In a preparation with a cartilage element and a bone
element, only the peripheral region is equipped in the manner
described above, and the basal region forms part of the central
region (FIG. 5).
[0045] Depending on the quantity and type of cells available,
depending on the type of use enchondral or osteochondral defect
sites in joints or meniscus defects, human or veterinary medicine,
repair sites in loaded or less loaded joint areas, repair capacity
of the native tissue around the repair site, etc.), fewer of the
aforementioned measures are sufficient for a preparation to be
integrated well in the surrounding tissue during the healing phase
and to be implantable with simple means and with sufficient primary
stability.
[0046] That is, in other words, a preparation in accordance with
the invention can have, for example, at least in its cartilage
part, a homogeneous matrix, and in the peripheral and/or basal
regions thereof an adhesive activatable in situ and/or equipped
with an inflammation-inhibiting agent. In such a case the
peripheral and basal regions make up very little of the total
volume of the cartilage part. On the other hand, the preparation in
accordance with the invention may comprise nothing else of the
inventive features than a matrix, whose structure in the central
region is different from the structure in the peripheral region,
especially less porous.
* * * * *